Shuo Sha | Hypertension | Best Researcher Award

Dr. Shuo Sha | Hypertension | Best Researcher Award

Dr. Shuo Sha, The First Hospital of Shanxi Medical University, China

Dr. Sha Shuo is a dedicated PhD candidate at Shanxi Medical University, specializing in Internal Medicine. She began her academic journey in August 2023 and is expected to graduate by June 2027. With a commitment to full-time study, Dr. Sha exemplifies perseverance and academic excellence in her pursuit of higher education. Her research focuses on advancing knowledge in the field of Internal Medicine, aiming to contribute significantly to healthcare innovation. πŸŽ“

 

Publication profile

Scopus

πŸŽ“ Education

Sha Shuo is currently pursuing her PhD in Internal Medicine at Shanxi Medical University. She joined the graduate school in August 2023 under a full-time format and is expected to graduate by June 2027.

Research Focus

Dr. Sha Shuo’s research focuses on energy-efficient automatic train operation for high-speed railways, with a particular emphasis on discrete notches and neutral sections. She investigates how these elements impact overall energy consumption and operational efficiency. By studying these factors, Dr. Sha aims to optimize train performance and energy usage, contributing to sustainable transportation solutions πŸš„. Her work integrates theoretical models with practical applications, aiming to enhance the reliability and environmental sustainability of high-speed rail networks through innovative operational strategies and technological advancements in railway systems.

 

Publication Top Notes

Energy-efficient automatic train operation for high-speed railways: Considering discrete notches and neutral sections

Makram Abou Ghaid | Medicine and Dentistry | Best Researcher Award

Makram Abou Ghaid | Medicine and Dentistry | Best Researcher Award

Dr Makram Abou Ghaida, Lebanese American University, Lebanon

Dr. Makram Abou Ghaida is a Post-Doctoral Research Fellow at the Lebanese American University (LAU) πŸš€. He earned his Doctor of Medicine from LAU in 2018 πŸŽ“ and completed a General Surgery residency at LAUMC-Rizk Hospital in 2023 πŸ₯. Dr. Abou Ghaida has a Bachelor’s Degree in Biology from LAU (2014) πŸ“˜. He currently serves as a Laparoscopy Simulation Instructor and a General Surgery Moonlighter at Clemenceau Medical Center 🌟. His research interests include colorectal cancer and major vascular injuries, with several publications to his name πŸ“š. Dr. Abou Ghaida is also an active participant in medical workshops and training programs πŸ’‘.

Publication profile

orcid

Education

Dr.Makram Abou Ghaida is a distinguished medical professional currently serving as a Post-Doctoral Research Fellow at the Lebanese American University (LAU) Research Department. They obtained their Doctor of Medicine (M.D.) from the LAU Gilbert and Rose-Marie Chagoury School of Medicine, Byblos, in 2018 🩺. In 2023, Dr. [Name] completed a General Surgery residency at LAUMC-Rizk Hospital in Beirut. They hold a Bachelor’s Degree in Biology from LAU, earned in Spring 2014 🌿. Dr. [Name]’s academic foundation was laid at Marjayoun National College (MNC), where they completed the Lebanese Baccalaureate in Life Sciences in 2011 πŸŽ“.

Experience

Dr. Makram Abou Ghaida is a dedicated Laparoscopy Simulation Instructor at the Lebanese American University, where they also supervise General Surgery Residents 🩻. They currently moonlight in the General Surgery Department at Clemenceau Medical Center 🌟. With a robust foundation in general surgery from their five-year residency at LAU πŸ₯, they also bring research prowess as a Post-Doctoral Research Fellow in LAU’s Research Department πŸ“Š. Dr. [Your Name] has diverse medical experience, from an elective in vascular surgery at the University of Illinois, Chicago 🏫, to extensive exposure through internships and research in colorectal cancer πŸŽ“. Their early dedication is evident from roles in Lebanese Scouts and Red Cross πŸ›‘οΈ, along with academic involvement in chemistry labs and tutoring πŸ“š.

Presentations

Dr. Makram Abou Ghaida, an esteemed member of the Lebanese Society for General Surgery, has presented pivotal surgical insights at prestigious annual conferences. In June 2023, Dr. [Your Name] addressed Idiopathic Gastroptosis and Gastroparesis 🩺, offering innovative perspectives on these challenging gastrointestinal conditions. The previous year, in June 2022, the focus was on Median Arcuate Ligament Syndrome (MALS) πŸ«€, providing critical updates and treatment strategies for this rare vascular condition. Dr. [Your Name]’s contributions continue to influence the surgical field, demonstrating a commitment to advancing medical knowledge and improving patient outcomes.

Research focus

Dr. Makram Abou Ghaida’s research primarily spans vascular surgery, with significant contributions to handling major vascular injuries, particularly highlighted in the context of the Beirut Blast πŸ₯πŸ’₯. He has also explored the use of laparoscopic sleeve gastrectomy for oncologic purposes, extending beyond traditional guidelines to investigate its efficacy in cancer treatment πŸ’‰πŸ”¬. Additionally, Dr. Abou Ghaida has delved into infectious diseases, as evidenced by his work on disseminated tuberculosis in patients with underlying conditions like Crohn’s disease 🧫🦠. His multidisciplinary approach reflects a robust focus on surgical innovations and complex medical cases.

Publication top notes

Vascular surgery experience for major vascular injuries in the Beirut Blast: Lessons learned

Laparoscopic Sleeve Gastrectomy as a First Step Procedure for Oncologic Purposes: An Indication Beyond the Updated Guidelines

A Case Report: Fatal Case of Disseminated Tuberculosis in a 24-year-old Male Patient with Crohn’s Disease

 

 

 

Tang Gao | Medicine and Dentistry | Best Researcher Award

Dr. Tang Gao | Medicine and Dentistry | Best Researcher Award

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China

Dr. Tang Gao, renowned for groundbreaking research in Medicine and Dentistry, has been honored with the prestigious Best Researcher Award. His exceptional contributions at Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China, have significantly advanced healthcare knowledge and patient care. πŸ† Dr. Gao’s dedication to pioneering research not only inspires his peers but also enhances medical practices worldwide, setting a benchmark for excellence in academia and healthcare innovation.

Profile

Google Scholar

Education

Dr. Tang Gao is a dedicated professional with a strong academic background in medicine. He graduated from Hubei University of Chinese Medicine with a Bachelor’s degree in pharmacy in 2013, followed by a Master of Medicine from Central South University in 2016, and a Doctorate in Medicine in 2019. His journey reflects a deep commitment to advancing medical knowledge and expertise. πŸŽ“ Dr. Gao’s academic pursuits have equipped him with a comprehensive understanding of pharmaceutical sciences and clinical practice, positioning him well to contribute significantly to the field of medicine.

Research and work experience

Dr. Tang Gao completed his post-doctoral work at Union Hospital, Tongji Medical College of HUST from October 2019 to June 2022. Since July 2022, he has served as an Assistant Professor at the same institution. His research focuses on [mention specific research interests if known]. With a commitment to advancing medical knowledge and education, Dr. Gao brings a wealth of experience and dedication to his role. πŸŽ“ His contributions to academia and healthcare underscore his passion for bridging theory with practical application in medicine.

Projects

Dr. Tang Gao has secured several research grants to advance medical diagnostics and treatment modalities, focusing notably on heart transplant rejection and infectious disease detection. 🌟 His projects include developing activatable bionic probes targeting macrophages for early heart transplant rejection diagnosis, utilizing smart fluorescence/photoacoustic molecular probes for acute rejection diagnosis, and innovating rapid SARS-CoV-2 antibody detection methods. These efforts are supported by various foundations and institutions, highlighting his contributions to both clinical and research fields. Dr. Gao’s work underscores a commitment to integrating advanced biomedical technologies for improving patient outcomes and healthcare efficacy. 🧬

Academic awards

Dr. Tang Gao has achieved remarkable recognition in the field of medicine, notably earning accolades such as the Outstanding Doctoral Dissertation of Hunan Province and being named among the Outstanding Graduates of the region. His contributions to natural science have been acknowledged with the Second Prize of the Natural Science Award of Hunan Province. Additionally, he has been honored with the Chinese Medical Association Youth Science and Technology Award, highlighting his dedication and innovation in medical research and practice. 🌟 Dr. Gao’s accomplishments underscore his commitment to advancing healthcare and scientific knowledge.

Publications Top Notes

 

Dan Yan | Medicine and Dentistry | Best Researcher Award

Dan Yan | Medicine and Dentistry | Best Researcher AwardΒ 

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. πŸ“šβœ¨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.

 

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: Whether a specific approach is justified to tackle the challenges?

Antibiotic combinations prediction based on machine learning to multicentre clinical data and drug interaction correlation

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment

Ξ²-Elemene in zedoary turmeric oil injection induces dyspnea by binding to hemoglobin and upregulating HIF-1Ξ±

Predicting coronary heart disease in Chinese diabetics using machine learning

Editorial: Benefits and risks of drug combination therapy for chronic metabolic diseases

Quality assessment and control of Shuanghuanglian Lyophilized Injection based on cell response spectrumΒ 

Forough Saki | Medicine and Dentistry | Best Researcher Award

Forough Saki | Medicine and Dentistry | Best Researcher Award

Assoc Prof Dr Forough Saki,Shiraz University of Medical sciences,Iran

πŸ‘©β€βš•οΈ Assoc Prof Dr. Forough Saki is a highly accomplished medical professional with expertise in Pediatric Endocrinology. She earned her MD from Shiraz University of Medical Sciences, followed by specialty training in Pediatrics and subspecialty in Pediatric Endocrinology. Dr. Saki has garnered numerous awards for her academic and research achievements, including being recognized as a Distinguished Researcher and receiving awards for her contributions to medical science. She serves as an academic staff and medical lecturer at Shiraz University of Medical Sciences, where she imparts knowledge in various specialties including diabetes, growth disorders, and thyroid disorders. With a prolific publication record and teaching experience, Dr. Saki continues to make significant contributions to the field of pediatric endocrinology.

Publication profile

google scholar

Education

Forough Saki pursued her education at Shiraz University of Medical Sciences, where she obtained her MD degree in Medicine in September 2004. Continuing her academic journey, she specialized in Pediatrics from September 2006 to September 2009. Dr. Saki further honed her expertise with a subspecialty in Pediatric Endocrinology from September 2011 to September 2013, demonstrating a commitment to advancing her medical knowledge and skills.

Awards

Dr. Saki’s exceptional academic and research achievements have been recognized through numerous awards. In 2009, she secured the first position in the pediatric residency board exam in Iran, showcasing her outstanding performance and dedication to pediatric medicine. Subsequently, she attained the second position at the Pediatric Endocrinology and Metabolism Research Center in 2013, highlighting her expertise in this specialized field. Dr. Saki’s contributions have not only been acknowledged locally but also nationally, as evidenced by the Award of selected physician of the medical council in Iran in 2010. Her commitment to research excellence earned her the Award of selected researcher in Shiraz University of Medical Sciences from 2014 to 2016, underscoring her significant contributions to advancing medical knowledge. Additionally, her impactful research was recognized internationally, as she received the Award of selected poster at the International Pediatric Congress in Iran in 2018, further solidifying her reputation as a distinguished researcher in the field of pediatrics. Dr. Saki’s dedication to research excellence was also acknowledged within her academic institution, as she was honored as a Distinguished Researcher in the Shiraz Student Research Committee of SMS in both 2012 and 2013, reflecting her ongoing commitment to advancing medical knowledge and fostering academic excellence.

 

Research focus

This individual, with an extensive educational background in medicine and pediatric endocrinology, has established themselves as a prominent figure in academia and research. Their research focuses primarily on various aspects of pediatric endocrinology, including bone disorders, diabetes, mineral metabolism, and hormonal imbalances. They have contributed significantly to understanding the pathophysiology of diseases like thalassemia, celiac disease, and epilepsy in children, while also exploring the effects of different treatments and interventions. Their dedication to teaching and research has earned them numerous awards and accolades, reflecting their commitment to advancing medical knowledge and improving pediatric healthcare. πŸ“šπŸ‘¨β€πŸ”¬

Publication top notes

Thyroid function in pregnancy and its influences on maternal and fetal outcomes

Incidence, Risk Factors and Causes of Severe Neonatal Hyperbilirubinemia in South of Iran (Fars Province)

Vitamin D deficiency and its associated risk factors in children and adolescents in southern Iran

Prevalence of Childhood Obesity and Hypertension in South of Iran

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy

Thyroid autoimmunity in pregnancy and its influences on maternal and fetal outcome in Iran (a prospective study)

Prevalence of celiac disease in patients with type 1 diabetes mellitus in the south of Iran

Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran

An ICET-A survey on occult and emerging endocrine complications in patients with Ξ²-thalassemia major: Conclusions and recommendations

Effect of posttraumatic serum thyroid hormone levels on severity and mortality of patients with severe traumatic brain injury

The effects of L-carnitine on renal function and gene expression of caspase-9 and Bcl-2 in monosodium glutamate‐induced rats

Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus

Intraventricular Hemorrhage in Premature Infants and Its Association with Pneumothorax

The effect of aromatherapy by lavender oil on infant vaccination pain: a double blind randomized controlled trial

An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report

Metabolic Syndrome, Insulin Resistance and Fatty Liver in Obese Iranian Children

Juvenile Paget’s disease in an Iranian kindred with vitamin D deficiency and novel homozygousΒ TNFRSF11BΒ mutation

The protective effect of Zataria multiflora Boiss. hydroalcoholic extract on TNF-Ξ± production, oxidative stress, and insulin level in streptozotocin-induced diabetic rats

Clinical and genetic features in patients with cystic fibrosis in southwestern iran

DIAGNOSTIC ACCURACY OF UREA BREATH TEST FORΒ HELICOBACTER PYLORIΒ INFECTION IN CHILDREN WITH DYSPEPSIA IN COMPARISON TO …

Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Dr. Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Dr. Amsalu Defersha, United States International University-Africa, Kenya

Dr. Amsalu Defersha, a renowned Clinical Pharmacist and Lecturer, holds a PhD in Clinical Pharmacy from the University of Nairobi. With extensive experience spanning academia and practice, he has taught at prestigious institutions like Ambo University and University of Gondar. A registered Pharmacist in Kenya and Ethiopia, Dr. Defersha’s expertise lies in Pharmacology and Clinical Pharmacy. He’s received notable awards, including scholarships from the European Union and Addis Ababa University. A prolific researcher, he’s secured grants for studies on cancer treatment outcomes. Dr. Defersha’s publications contribute significantly to the field, enhancing patient care and medication management. πŸŽ“πŸ’ŠπŸ“š

 

Publication Profile

Orcid

Google Scholar

πŸŽ“ Academic Background

Dr. Amsalu Defersha boasts a rich academic journey, culminating in a PhD in Clinical Pharmacy from the University of Nairobi. Prior to this, he earned a Master of Science in Pharmacology from Addis Ababa University and a Master of Pharmacy in Clinical Pharmacy from the University of Nairobi. His educational foundation began with a Bachelor of Pharmacy from Jimma University, Ethiopia.

πŸ† Awards and Recognition:

Dr. Defersha’s academic prowess has been recognized with prestigious awards, including the Intra ACP AFIMEGQ Scholarship from the European Union for his Master of Pharmacy studies in Clinical Pharmacy at the University of Nairobi. Additionally, he received a scholarship for his Master of Science studies in Pharmacology from Addis Ababa University.

πŸ”¬ Research Grants

Dr. Defersha has secured notable grants for impactful studies. His 2018 research grant from the United States International University-Africa funded a study on treatment outcomes among adult patients with solid malignancies at Kenyatta National Hospital. In 2022, he received another grant to evaluate drug-related problems and treatment outcomes among patients with gastrointestinal cancers

πŸ” Research Focus

Dr. Amsalu Defersha’s research primarily centers around pharmaceutical care and clinical outcomes, particularly in the context of chronic diseases such as diabetes, cancer, and cardiovascular disorders. His work delves into medication adherence, drug therapy problems, and treatment outcomes among ambulatory and hospitalized patients. Through systematic reviews, he also explores healthcare provider knowledge and practices, especially during public health crises like the COVID-19 pandemic. With a focus on improving patient care and medication management, Dr. Defersha’s research contributes significantly to enhancing healthcare delivery and optimizing therapeutic interventions. πŸ“ŠπŸ’ŠπŸ”¬

 

Publication Top NotesΒ 

πŸ“šNonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital – Published in Journal of Diabetes Research, 2014 – Cited by 102 times

πŸ“š Evaluation of the anti-diarrheal activity of the leaf extract ofΒ Croton macrostachyusΒ Hocsht. ex Del. (Euphorbiaceae) in mice model– Published in BMC Complementary and Alternative Medicine, 2016 – Cited by 80 times

πŸ“š Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya, 2017 – Cited by 37 times

πŸ“š Level of adherence to the dietary recommendation and glycemic control among patients with type 2 diabetes mellitus in Eastern Ethiopia: a cross-sectional study– Published in Diabetes, Metabolic Syndrome and Obesity, 2020 – Cited by 31 times

πŸ“šFactors affecting health-related quality of life among prostate cancer patients: a systematic review, 2020 – Cited by 27 times

Surgical site infections and prophylaxis antibiotic use in the surgical ward of public hospital in Western Ethiopia: a hospital-based retrospective cross-sectional study

Medication‐related problems and adverse drug reactions in Ethiopia: A systematic review

Prevalence and risk factors of thromboembolism among patients with coronavirus disease-19: a systematic review and meta-analysis

Knowledge, attitude, and practice of healthcare providers toward novel coronavirus 19 during the first months of the pandemic: a systematic review

Evaluation of the antidiarrheal activity of hydromethanol crude extracts of Ruta chalepensis and Vernonia amygdalina in mice

 

Mahdi Malakoutikhah | Health Professions | Health Professions

Dr. Mahdi Malakoutikhah | Health Professions | Health Professions

Dr. Mahdi Malakoutikhah, Kashan University of Medical Sciences, Iran

Dr. Mahdi Malakoutikhah is a distinguished scholar in Occupational Health and Safety, holding a Ph.D. from Shiraz University of Medical Sciences. He earned his B.Sc. and M.Sc. from Kashan and Tehran Universities of Medical Sciences, respectively. His expertise encompasses fire risk assessment, unsafe behavior modeling, and COVID-19 workplace prevention. Dr. Malakoutikhah has excelled academically, achieving top rankings in his field and authoring insightful books on occupational health. With a passion for enhancing workplace safety, he combines theoretical frameworks like Granded Theory and System Dynamics with practical applications. His contributions significantly impact worker well-being and organizational safety practices. πŸŽ“πŸ”₯πŸ‘¨β€πŸ”¬

Publication Profile:

Scopus

Google Scholar

 

Educational background:

Dr. Mahdi Malakoutikhah pursued a dedicated academic journey in Occupational Health and Safety, spanning three prestigious institutions in Iran. Beginning with his Bachelor’s degree at Kashan University of Medical Sciences from 2010 to 2014, he laid the groundwork for his specialization. He furthered his education with a Master’s degree at Tehran University of Medical Sciences, where he deepened his understanding from 2015 to 2017. Finally, Dr. Malakoutikhah culminated his scholarly pursuits with a Ph.D. from Shiraz University of Medical Sciences between 2018 and 2021, solidifying his expertise in the field. His commitment to occupational health and safety is reflected in his extensive academic journey. πŸŽ“

 

Achievement:

Dr. Mahdi Malakoutikhah’s academic journey is adorned with notable achievements, underscoring his prowess in Occupational Health and Safety. In 2014, he clinched the top spot in his Master’s exam, showcasing his exceptional understanding of the discipline. Continuing his success, he secured the 16th rank in the Ph.D. exam in 2017, a testament to his dedication and knowledge. His excellence was further recognized with a Grade A in the comprehensive doctoral exam in 2019, solidifying his expertise. Moreover, Dr. Malakoutikhah’s leadership shone brightly as he attained the top rank in the inaugural safety startup event of 2019, marking his innovative contributions to the field. πŸ†

Research Focus:

Dr. Mahdi Malakoutikhah’s research focus spans a wide array of topics within occupational health and safety, showcasing his versatility and depth of expertise. He delves into areas such as the analysis of individual and social factors affecting occupational accidents, the prevalence of musculoskeletal disorders among various occupational groups, and the development of comprehensive risk assessment methodologies. Additionally, he investigates the impact of psychosocial factors on workplace injuries, the effectiveness of safety interventions, and the modeling of unsafe behaviors among workers. His dedication to improving workplace health and safety through rigorous scientific inquiry is evident, making him a pivotal figure in the field. πŸ§ͺπŸ”¬

Publication Top Notes:

  1. An analysis of individual and social factors affecting occupational accidents – Cited by 81 (2019) πŸ“Š
  2. THE SURVIVAL RATE OF HEPATOCELLULAR CARCINOMA IN ASIAN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS – Cited by 52 (2020) πŸ“‘
  3. Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis – Cited by 43 (2020) 🩺
  4. The global prevalence of musculoskeletal disorders among operating room personnel: a systematic review and meta-analysis – Cited by 42 (2020) πŸ’Ό
  5. Epidemiology and risk factors of needlestick injuries among healthcare workers in Iran: a systematic reviews and meta-analysis – Cited by 36 (2021) 🩹
  6. Using fuzzy logic approach to predict work-related musculoskeletal disorders among automotive assembly workers – Cited by 25 (2019) πŸ”
  7. Analyzing the Risk of Fire in a Hospital Complex by β€œFire Risk Assessment Method for Engineering”(FRAME)– Cited by 22 (2014) πŸ”₯
  8. Investigation of psychosocial factors on upper limb musculoskeletal disorders and the prevalence of its musculoskeletal disorders among nurses: a systematic review and meta … – Cited by 21 (2021) πŸ‘©β€βš•οΈ
  9. Modeling of relationship between work-family conflict and occupational accident in a steel manufacturing industry – Cited by 20 (2017) 🏭
  10. The factors affecting unsafe behaviors of Iranian workers: a qualitative study based on grounded theory – Cited by 19 (2021) πŸ› οΈ

 

 

 

Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

πŸ‘©β€βš•οΈ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

πŸ“š Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. πŸŽ“ Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

πŸ“ Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

πŸ” Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes: